Osteopontin Reduced Hypoxia–Ischemia Neonatal Brain Injury by Suppression of Apoptosis in a Rat Pup Model
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background and Purpose—: Osteopontin (OPN) is neuroprotective in ischemic brain injuries in adult experimental models; therefore, we hypothesized that OPN would provide neuroprotection and improve long-term neurological function in the immature brain after hypoxic–ischemic (HI) injury. Methods—: HI was induced by unilateral ligation of the right carotid artery followed by hypoxia (8% O 2 for 2 hours) in postnatal Day 7 rats. OPN (0.03 μg or 0.1 μg) was injected intracerebroventricularly at 1 hour post-HI. Temporal expression of endogenous OPN was evaluated in the normal rat brain at the age of 0, 4, 7, 11, 14, and 21 days and in the ipsilateral hemisphere after HI. The effects of OPN were evaluated using 2-3-5-triphenyl tetrazolium chloride staining, apoptotic cell death assay, and cleaved caspase-3 expression. Neurological function was assessed by the Morris water maze test. Results—: Endogenous OPN expression in the brain was the highest at the age of 0 day with continuous reduction until the age of 21 days during development. After HI injury, endogenous OPN expression was increased and peaked at 48 hours. Exogenous OPN decreased infarct volume and improved neurological outcomes 7 weeks after HI injury. OPN-induced neuroprotection was blocked by an integrin antagonist. Conclusions—: OPN-induced neuroprotection was associated with cleaved-caspase-3 inhibition and antiapoptotic cell death. OPN treatment improved long-term neurological function against neonatal HI brain injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Cai, Z., Pang, Y., Lin, S., & Rhodes, P. G. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02545-9 · Cited by 173
Cited by
Extracellular matrix and matrix receptors in blood–brain barrier formation and stroke
Baeten, K. M., & Akassoglou, K. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20954 · Cited by 397
“After ischemia, OPN is expressed in neurons, macrophages, and astrocytes in the neonate, while in the adult brain OPN is upregulated in microglia and macrophages around the infarct zone (Ellison et al., 1998; Wang et al., 1998a; Chen et al., 2011).”
BackgroundInfluentialNeuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy
Dixon, B., Reis, C., Ho, W., Tang, J., & Zhang, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160922368 · Cited by 182
“According to Chen and colleagues, OPN-induced neuroprotection was associated with cleaved caspase-3 inhibition and anti-apoptotic cell death, thereby improving long-term neurological function against neonatal HIE brain injury [137].”
BackgroundSelf-citationCellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases
Chen, D., Zhang, T., & Lee, T. H. (2020) · Biomolecules · doi:10.3390/biom10081158 · Cited by 140
Bin-Jaliah, I., & Sakr, H. (2018) · Physiology International · doi:10.1556/2060.105.2018.1.1 · Cited by 20
“In addition, the upregulation of OPN aids in inhibiting cleaved caspase-3 (10).”
BackgroundOsteopontin heptamer peptide containing the RGD motif enhances the phagocytic function of microglia
Dashdulam, D., Kim, I.-D., Lee, H., Lee, H.-K., Kim, S.-W., & Lee, J.-K. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.100 · Cited by 16
Metadata
- Authors
- Chen, W., Ma, Q., Suzuki, H., Hartman, R., Tang, J., & Zhang, J. H.
- Venue
- Stroke
- Published
- 2011-03
- Volume
- 42
- Issue
- 3
- Pages
- 764-769
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2155088824
- Cited by
- 83
- References
- 2
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.